Terms: = Bone cancer AND STAT6, D12S1644, 6778, ENSG00000166888, IL-4-STAT, P42226, STAT6B, STAT6C AND Treatment
14 results:
1. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.
Kojima D; Ohba S; Abe M; Suzuki A; Horibe S; Tateya I; Hasegawa M; Hirose Y
Neuropathology; 2022 Oct; 42(5):453-458. PubMed ID: 35880350
[TBL] [Abstract] [Full Text] [Related]
2. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract] [Full Text] [Related]
3. A case of primary orbital solitary fibrous tumor with lung metastases 41 years after initial treatment.
Tanabe M; Yoshikawa H; Yamada Y; Oda Y; Sonoda KH
Orbit; 2022 Dec; 41(6):810-814. PubMed ID: 34261401
[TBL] [Abstract] [Full Text] [Related]
4. Skull Base Tumors: Neuropathology and Clinical Implications.
Bi WL; Santagata S
Neurosurgery; 2022 Mar; 90(3):243-261. PubMed ID: 34164689
[TBL] [Abstract] [Full Text] [Related]
5. Exploring the association mechanism between metastatic osteosarcoma and non-metastatic osteosarcoma based on dysfunctionality module.
Xiong J; Li T
J BUON; 2020; 25(3):1569-1578. PubMed ID: 32862606
[TBL] [Abstract] [Full Text] [Related]
6. Angiosarcoma of the Temporal bone: Case Report and Review of the Literature.
Bernstock JD; Shafaat O; Hardigan A; Fox BM; Moore LS; Chagoya G; Elsayed G; Gessler F; Ilyas A; Yamashita D; McGrew B; Fisher WS; Hackney J; Sotoudeh H
World Neurosurg; 2019 Oct; 130():351-357. PubMed ID: 31330332
[TBL] [Abstract] [Full Text] [Related]
7. Sinonasal Tract Solitary Fibrous Tumor: A Clinicopathologic Study of Six Cases with a Comprehensive Review of the Literature.
Thompson LDR; Lau SK
Head Neck Pathol; 2018 Dec; 12(4):471-480. PubMed ID: 29282671
[TBL] [Abstract] [Full Text] [Related]
8. MEK1/2 Inhibition Promotes Macrophage Reparative Properties.
Long ME; Eddy WE; Gong KQ; Lovelace-Macon LL; McMahan RS; Charron J; Liles WC; Manicone AM
J Immunol; 2017 Jan; 198(2):862-872. PubMed ID: 28003382
[TBL] [Abstract] [Full Text] [Related]
9. IL-4 enhances expression and function of surface IgM in CLL cells.
Aguilar-Hernandez MM; Blunt MD; Dobson R; Yeomans A; Thirdborough S; Larrayoz M; Smith LD; Linley A; Strefford JC; Davies A; Johnson PM; Savelyeva N; Cragg MS; Forconi F; Packham G; Stevenson FK; Steele AJ
Blood; 2016 Jun; 127(24):3015-25. PubMed ID: 27002119
[TBL] [Abstract] [Full Text] [Related]
10. Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer.
Cummings CT; Linger RM; Cohen RA; Sather S; Kirkpatrick GD; Davies KD; DeRyckere D; Earp HS; Graham DK
Oncotarget; 2014 Nov; 5(21):10434-45. PubMed ID: 25372020
[TBL] [Abstract] [Full Text] [Related]
11. Novel pathways and molecular targets for the treatment of sarcoma.
Frith AE; Hirbe AC; Van Tine BA
Curr Oncol Rep; 2013 Aug; 15(4):378-85. PubMed ID: 23661264
[TBL] [Abstract] [Full Text] [Related]
12. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.
Klepstad P; Fladvad T; Skorpen F; Bjordal K; Caraceni A; Dale O; Davies A; Kloke M; Lundström S; Maltoni M; Radbruch L; Sabatowski R; Sigurdardottir V; Strasser F; Fayers PM; Kaasa S;
Pain; 2011 May; 152(5):1139-1145. PubMed ID: 21398039
[TBL] [Abstract] [Full Text] [Related]
13. Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via stat6 and preserves graft-versus-leukemia effects.
Reddy P; Teshima T; Hildebrandt G; Williams DL; Liu C; Cooke KR; Ferrara JL
Blood; 2003 Apr; 101(7):2877-85. PubMed ID: 12433681
[TBL] [Abstract] [Full Text] [Related]
14. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction.
Haque SJ; Harbor P; Tabrizi M; Yi T; Williams BR
J Biol Chem; 1998 Dec; 273(51):33893-6. PubMed ID: 9852037
[TBL] [Abstract] [Full Text] [Related]
